Editorial: Emerging Infectious and Vector-Borne Diseases: A Global Challenge

Frontiers in Public Health

article

Katherine M. Warpeha¹  Vincent Munster²  Catherine Mullié³  Shu Hui Chen⁴ 

[1] Department of Biological Sciences, University of Illinois at Chicago, United States;National Institute of Allergy and Infectious Diseases (NIAID) and National Institutes of Health, United States;Laboratoire AGIR (Agents Infectieux, University of Picardy Jules Verne;National Institutes of Health (NIH), United States

关键词: infectious disease;    vector-borne;    zoonotic;    viral;    containment;    diagnostics;    climate change;    plant-animal interaction;   

DOI  :  10.3389/fpubh.2020.00214

学科分类：社会科学、人文和艺术（综合）

来源: Frontiers

【 摘 要 】

This Special Research Topic focused on global challenges in identification, transfer, spread,treatment, and containment of infectious and vector-borne diseases (including re-emerginginfectious diseases). Research, medical and community leaders have come together to addressinfectious and zoonotic or vector-borne diseases by making a public and proactive shift fromreactionary to pre-emptive approaches to address diseases. Eight articles of current importancewere published in this special issue.The World Health Organization’s Global vector control response 2017–2030 (GVCR)1 hasdirected a new strategy to strengthen vector monitoring and control worldwide, stating thatthrough increased capacity, improved surveillance and response in coordinating and integratingactions, disease can be prevented/managed. In 2017, the World Health Assembly adopted aresolution (WHA 70.16: An integrated approach for the control of vector-borne diseases2) askingMember States for strategies to implement vector control. 2020 goals include Reduction in: (i)mortality due to vector-borne diseases globally relative to 2016 (by 30%), (ii) case incidence due tovector-borne diseases globally relative to 2016 (by 25%), and to ask of all countries to contain spreadof disease to prevent epidemics of vector-borne diseases. This issue includes articles highlightinghost immune responses and development of biomarkers that may assist in disease management.Wang et al., shows that host antibodies to the Plasmodium TatD-like DNase protected mousemodels from infection (Wang et al.). The identification of the serologic biomarker, SjSP-13, showpromise as diagnostics and may prove valuable for surveillance and containment (Xu et al.).

【 授权许可】

CC BY